Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial

A skin cancer vaccine developed by a Tampa company is entering “phase one” of clinical trials.

UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.